The HO-1-dependent enhanced cellular resistance can be expected to complement current medical modalities for much effective control of the COVID-19 pandemic, especially in the absence of broadly protective vaccines and the limited choice of therapeutic options to treat post-infection conditions and associated severe secondary complications. The gene discussed is HMOX1; the disease is infection.